Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Chika Ogami"'
Autor:
Yasutoshi Kuboki, Masafumi Ikeda, Shigehisa Kitano, Takafumi Koyama, Noboru Yamamoto, Yuki Yamaguchi, Yuki Nakagawa, Takaaki Ishida, Hidenori Mizugaki, Takatsugu Narikiyo, Ryoko Takubo, Chika Ogami, Mayuko Sekiya
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Immunosuppressive conditions within the tumor microenvironment (TME) can allow tumors to evade the immune system, including by hampering programmed death ligand 1 (PD-L1) inhibitor activity. Interleukin (IL)-8 contributes to immunosuppress
Externí odkaz:
https://doaj.org/article/3d04b9ef93094c8580ba143d1ba1c0ee
Autor:
Chika Ogami, Yasuhiro Tsuji, Hiroto Seki, Hideaki Kawano, Hideto To, Yoshiaki Matsumoto, Hiroyuki Hosono
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 7, Pp 760-768 (2021)
Abstract We developed a method to apply artificial neural networks (ANNs) for predicting time‐series pharmacokinetics (PKs), and an interpretable the ANN‐PK model, which can explain the evidence of prediction by applying Shapley additive explanat
Externí odkaz:
https://doaj.org/article/ea378b8796b448b7b48260805607fd56
Autor:
Hitoshi Kawasuji, Yasuhiro Tsuji, Chika Ogami, Kou Kimoto, Akitoshi Ueno, Yuki Miyajima, Koyomi Kawago, Ippei Sakamaki, Yoshihiro Yamamoto
Publikováno v:
BMC Pharmacology and Toxicology, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Linezolid is administered as a fixed dose to all patients despite evidence of overexposure and thrombocytopenia in renal impairment. The aims of this study were to evaluate the risk of thrombocytopenia and the utility of therapeut
Externí odkaz:
https://doaj.org/article/3dc73e5bc7ca403b95665119efb984ec
Autor:
Yushi Murai, Hitoshi Kawasuji, Yusuke Takegoshi, Makito Kaneda, Kou Kimoto, Akitoshi Ueno, Yuki Miyajima, Koyomi Kawago, Yasutaka Fukui, Chika Ogami, Ippei Sakamaki, Yasuhiro Tsuji, Yoshitomo Morinaga, Yoshihiro Yamamoto
Publikováno v:
International Journal of Infectious Diseases, Vol 106, Iss , Pp 33-35 (2021)
As of October 2020, there is still no specific drug to treat COVID-19 as it rages worldwide. Favipiravir, indicated for the treatment of new and re-emerging influenza infections, has been suggested to be effective against SARS-CoV-2, although this is
Externí odkaz:
https://doaj.org/article/cae3ac15a41a45d6a7460232bea684d7
Autor:
Chika Ogami, Yasuhiro Tsuji, Hidefumi Kasai, Yoichi Hiraki, Yoshihiro Yamamoto, Kazuhisa Matsunaga, Yoshiharu Karube, Hideto To
Publikováno v:
International Journal of Infectious Diseases, Vol 57, Iss C, Pp 38-43 (2017)
Background: Daptomycin exhibits concentration-dependent antibacterial activity. By monitoring daptomycin serum concentrations, clinicians may be able to predict the effectiveness of treatments for infections more accurately. However, it has been repo
Externí odkaz:
https://doaj.org/article/642b01e862f3444cbc19489e7a41d6bb
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0214037 (2019)
Linezolid is an oxazolidinone antibiotic that effectively treats methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Since rifampicin induces other antibiotic effects, it is combined with linezolid in therap
Externí odkaz:
https://doaj.org/article/d047f5250f1d481595b72f5b9f288a50
Autor:
Hitoshi Kawasuji, Yasuhiro Tsuji, Chika Ogami, Makito Kaneda, Yushi Murai, Kou Kimoto, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Yoshihiro Yamamoto
Publikováno v:
Antibiotics, Vol 10, Iss 5, p 496 (2021)
This retrospective cohort study investigated the effects of an initially reduced linezolid dosing regimen in hemodialysis patients through therapeutic drug monitoring (TDM). Patients were divided into two groups depending on their initial dose of lin
Externí odkaz:
https://doaj.org/article/41331327c76842328692af7cc42ac7d1
Autor:
Saki Takahashi, Yasuhiro Tsuji, Nick Holford, Chika Ogami, Hidefumi Kasai, Hitoshi Kawasuji, Hideto To, Yoshihiro Yamamoto
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 48:201-211
Autor:
Yasuhiro Tsuji, Hiroto Seki, Chika Ogami, Hideto To, Yoshiaki Matsumoto, Hiroyuki Hosono, Hideaki Kawano
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 7, Pp 760-768 (2021)
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology
We developed a method to apply artificial neural networks (ANNs) for predicting time‐series pharmacokinetics (PKs), and an interpretable the ANN‐PK model, which can explain the evidence of prediction by applying Shapley additive explanations (SHA
Autor:
Harumi Yamada, Shin Kawai, Hitoshi Kawasuji, Hideto To, Yoshihiro Yamamoto, Chika Ogami, Yasuhiro Tsuji, Yoshifumi Nishi, Ippei Sakamaki
Publikováno v:
Journal of Infection and Chemotherapy. 27:165-171
Introduction Aims of this study were (a) to assess the development ratio of hyponatremia during treatment with linezolid and (b) to evaluate the relationship between the risk of hyponatremia and linezolid exposure and patient background. Method Clini